Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

6,065 total articles

Ivanhoe Mines: Buy the Rebuild, But Bring Patience

Ivanhoe Mines: Buy the Rebuild, But Bring Patience

Kakula's rebuild and ramp risk have created a window where patient, disciplined longs can buy optionality on a reworked copper engine. Trade plan: enter at $3.25, stop at $2.45, target $5.50 with a long-term horizon (180 trading days). Expect volatility while underground repairs and commissioning progress through mid-2026.

Zai Lab: Xacduro + ZL-1310 Catalyze a Re-Rate — Tactical Long

Zai Lab: Xacduro + ZL-1310 Catalyze a Re-Rate — Tactical Long

Zai Lab ($ZLAB) looks positioned for a renewed growth narrative driven by newer assets (Xacduro, ZL-1310) and recent regulatory momentum in China. The balance sheet and technicals support a tactical long trade: entry near current levels, a clear stop under recent support, and a target that prices in a successful commercial/clinical cadence over the…

Lumentum: Play the Optical Bottleneck - A Supply-Chain Reprice Trade

Lumentum: Play the Optical Bottleneck - A Supply-Chain Reprice Trade

Lumentum (LITE) sits squarely at the optical bottleneck for AI networking. Fundamentals and recent order flows point to continued tightness in high-end optics; the market still prices much of the company as a pure-growth, science play. We see a cleaner trade: buy exposure on a mid-term time frame to capture re-rating as supply normalizes but stays …

Meta at a Turning Point: A Trade for the AI Second Act

Meta at a Turning Point: A Trade for the AI Second Act

Meta is trading well below its 52-week high and offers a durable franchise, strong cash generation ($46.1B FCF), and reasonable valuation (~24x earnings). With AI infrastructure commitments, new product cycles, and a healthy balance sheet, we see a favorable risk/reward for a long trade targeting $720 over the next 180 trading days. Entry $576.50, …

Arista Networks: Buy the AI-Networking Compounder (Rating Upgrade)

Arista Networks: Buy the AI-Networking Compounder (Rating Upgrade)

Arista is uniquely positioned to capture the next wave of data center networking spend driven by AI. Strong 2025 results, a $5.4B deferred revenue backlog, and FCF of $4.25B support growth guidance and a durable moat. We upgrade to a buy with an entry at $127.50, a target of $177.50, and a stop at $115.00 — horizon: long term (180 trading days).

Intel: A Tactical Long as Helium Scarcity Reorders Foundry Economics

Intel: A Tactical Long as Helium Scarcity Reorders Foundry Economics

Intel (INTC) is a pragmatic long after regaining full control of Fab 34 and amid a scenario where U.S.-Iran friction could tighten helium supply for chip fabs. Combine improved balance-sheet moves, bullish momentum and a unique foundry footprint and the risk/reward supports a targeted trade: entry $51.38, stop $45.00, target $62.00 for a long-term …

Brookfield (BAM): 15% Payout Lift Makes a Yield-Plus Swing Buy at $44.47

Brookfield (BAM): 15% Payout Lift Makes a Yield-Plus Swing Buy at $44.47

Brookfield Asset Management just raised its distribution by 15% and continues to deploy into large deal flow (including a €1.2B Spanish multifamily purchase). At $44.47, the stock yields roughly 4.1% today — the raise pushes that toward ~4.7% — and offers a catalyst-rich setup for a mid-term swing. Valuation on cash-flow multiples is elevated, so p…

Moderna: High-Conviction, High-Risk Buy For mRNA Upside

Moderna: High-Conviction, High-Risk Buy For mRNA Upside

Moderna is trading at roughly $49 and a $19.4B market cap as it pivots from historic COVID revenues toward RSV, flu and oncology mRNA programs. Fundamentals remain challenged - negative EPS, negative free cash flow and a recent multi-billion-dollar legal settlement - but the stock already reflects optimism and a cleared legal overhang. This is a sp…

Fiserv Is Cheap Enough to Own, Not Cheap Enough to Sprint Higher

Fiserv Is Cheap Enough to Own, Not Cheap Enough to Sprint Higher

Fiserv (FISV) trades at single-digit earnings multiples, generates strong free cash flow and just attracted heavyweight interest from Baupost. The stock is deeply discounted relative to cash flow and historical multiples, but operational headwinds and a recent price collapse mean upside will be gradual. This is a long trade for investors willing to…